The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer - a multicentre observational study.
Sinan KhadhouriKevin M GallagherKenneth R MacKenzieTaimur T ShahChuanyu GaoSacha MooreEleanor F ZimmermannEric EdisonMatthew JefferiesArjun NambiarMiles P MannasTaeweon LeeGiancarlo MarraBeatrice LillazGómez Rivas JuanJonathan OlivierMark A AssmusTaha UçarFrancesco ClapsMatteo BoltriTara BurnhopeNkwam NkwamGeorge TanasescuNicholas E BoxallAlison P DowneyAsim A LalMarta Antón-JuanillaHolly ClarkeDavid H W LauKathryn GillamsMatthew CrockettMatthew NielsenYemisi TakwoingiNaomi ChuchuJohn O'RourkeGraeme MacLennanJohn S McGrathVeeru Kasivisvanathannull nullPublished in: BJU international (2021)
A better understanding of cancer prevalence across an international population is required to inform clinical guidelines. We are the first to report urinary tract cancer prevalence across an international population in patients referred to secondary care, adjusted for patient risk markers and geographical variation. Bladder cancer was the most prevalent disease. Visible haematuria was the strongest predictor for urinary tract cancer.
Keyphrases